A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth S Bonnet, SL Archer, J Allalunis-Turner, A Haromy, C Beaulieu, ... Cancer cell 11 (1), 37-51, 2007 | 1994 | 2007 |
An abnormal mitochondrial–hypoxia inducible factor-1α–Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities … S Bonnet, ED Michelakis, CJ Porter, MA Andrade-Navarro, B Thébaud, ... Circulation 113 (22), 2630-2641, 2006 | 682 | 2006 |
Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs VD Soleimani, VG Punch, Y Kawabe, AE Jones, GA Palidwor, CJ Porter, ... Developmental cell 22 (6), 1208-1220, 2012 | 193 | 2012 |
Gene function in early mouse embryonic stem cell differentiation KH Sene, CJ Porter, G Palidwor, C Perez-Iratxeta, EM Muro, PA Campbell, ... BMC genomics 8, 1-21, 2007 | 166 | 2007 |
GDB: the human genome database SI Letovsky, RW Cottingham, CJ Porter, PWD Li Nucleic acids research 26 (1), 94-99, 1998 | 163 | 1998 |
UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia A Benyoucef, CG Palii, C Wang, CJ Porter, A Chu, F Dai, V Tremblay, ... Genes & development 30 (5), 508-521, 2016 | 129 | 2016 |
Study of stem cell function using microarray experiments C Perez-Iratxeta, G Palidwor, CJ Porter, NA Sanche, MR Huska, ... FEBS letters 579 (8), 1795-1801, 2005 | 97 | 2005 |
Mtf2-PRC2 control of canonical Wnt signaling is required for definitive erythropoiesis JLM Rothberg, HB Maganti, H Jrade, CJ Porter, GA Palidwor, C Cafariello, ... Cell Discovery 4 (1), 21, 2018 | 55 | 2018 |
MLL1 is required for PAX7 expression and satellite cell self-renewal in mice GC Addicks, CE Brun, MC Sincennes, J Saber, CJ Porter, ... Nature Communications 10 (1), 4256, 2019 | 54 | 2019 |
Targeting the MTF2–MDM2 axis sensitizes refractory acute myeloid leukemia to chemotherapy HB Maganti, H Jrade, C Cafariello, JL Manias Rothberg, CJ Porter, ... Cancer discovery 8 (11), 1376-1389, 2018 | 52 | 2018 |
Managing all those bytes: the Human Genome Project AJ Cuticchia, MA Chipperfield, CJ Porter, W Kearns, PL Pearson Science 262 (5130), 47-48, 1993 | 37 | 1993 |
Arab genetic disease database (AGDDB): A population‐specific clinical and mutation database AS Teebi, SA Teebi, CJ Porter, AJ Cuticchia Human mutation 19 (6), 615-621, 2002 | 35 | 2002 |
CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma L Liang, L Coudière-Morrison, N Tatari, M Stromecki, A Fresnoza, ... Cancer Research 78 (16), 4745-4759, 2018 | 34 | 2018 |
MaSC: mappability-sensitive cross-correlation for estimating mean fragment length of single-end short-read sequencing data P Ramachandran, GA Palidwor, CJ Porter, TJ Perkins Bioinformatics 29 (4), 444-450, 2013 | 34 | 2013 |
Central mutation databases—a review CJ Porter, CC Talbot, Jr, AJ Cuticchia Human mutation 15 (1), 36-44, 2000 | 33 | 2000 |
Sex diversity in proximal tubule and endothelial gene expression in mice with ischemic acute kidney injury JL Viñas, CJ Porter, A Douvris, M Spence, A Gutsol, JA Zimpelmann, ... Clinical Science 134 (14), 1887-1909, 2020 | 32 | 2020 |
An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate J Zagozewski, GM Shahriary, LC Morrison, O Saulnier, M Stromecki, ... Nature Communications 11 (1), 3627, 2020 | 28 | 2020 |
A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine β-hydroxylase locus J Nahmias, MW Burley, S Povey, C Porter, I Craig, J Wolfe Human Molecular Genetics 1 (4), 286-286, 1992 | 28 | 1992 |
StemBase: a resource for the analysis of stem cell gene expression data CJ Porter, GA Palidwor, R Sandie, PM Krzyzanowski, EM Muro, ... Stem Cell Assays, 137-148, 2007 | 27 | 2007 |
Report of the fourth international workshop on human chromosome 16 mapping 1995. NA Doggett, MH Breuning, DF Callen Cytogenetics and cell genetics 72 (4), 271-293, 1996 | 26 | 1996 |